BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Prognosis
24 results:

  • 1. [Effects of BMAL2 on Aerobic Glycolysis and Cell Proliferation in Acute Myeloid leukemia Cells].
    Jia WJ; Mu J; Cui WJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):402-408. PubMed ID: 38660843
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Gene expression of carbonic anhydrase 9 (CA9) in
    Alyaqubi KJ; Dosh RH; Al-Fatlawi RB; Al-Rehemi SM; Hadi NR
    J Med Life; 2022 Sep; 15(9):1158-1163. PubMed ID: 36415514
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hypoxia-inducible factor 1α inhibitor induces cell death via suppression of BCR-ABL1 and Met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloid leukemia cells.
    Tsubaki M; Takeda T; Matsuda T; Kimura A; Tanaka R; Nagayoshi S; Hoshida T; Tanabe K; Nishida S
    BMB Rep; 2023 Feb; 56(2):78-83. PubMed ID: 36195570
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PARP14 promotes the growth and glycolysis of acute myeloid leukemia cells by regulating HIF-1α expression.
    Zhu Y; Liu Z; Wan Y; Zou L; Liu L; Ding S; Lu C; Qiu F
    Clin Immunol; 2022 Sep; 242():109094. PubMed ID: 35944879
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Role of Hypoxic Bone Marrow Microenvironment in Acute Myeloid leukemia and Future Therapeutic Opportunities.
    Bruno S; Mancini M; De Santis S; Monaldi C; Cavo M; Soverini S
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202238
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. JunB is a key regulator of multiple myeloma bone marrow angiogenesis.
    Fan F; Malvestiti S; Vallet S; Lind J; Garcia-Manteiga JM; Morelli E; Jiang Q; Seckinger A; Hose D; Goldschmidt H; Stadlbauer A; Sun C; Mei H; Pecherstorfer M; Bakiri L; Wagner EF; Tonon G; Sattler M; Hu Y; Tassone P; Jaeger D; Podar K
    Leukemia; 2021 Dec; 35(12):3509-3525. PubMed ID: 34007044
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CXCL2 benefits acute myeloid leukemia cells in hypoxia.
    Li L; Zhao L; Man J; Liu B
    Int J Lab Hematol; 2021 Oct; 43(5):1085-1092. PubMed ID: 33793061
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin.
    Wang Y; Liu Y; Bailey C; Zhang H; He M; Sun D; Zhang P; Parkin B; Baer MR; Zheng P; Malek SN; Liu Y
    Oncogene; 2020 Apr; 39(14):3015-3027. PubMed ID: 32060420
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. High PD‑L1 expression drives glycolysis via an Akt/mTOR/HIF‑1α axis in acute myeloid leukemia.
    Ma P; Xing M; Han L; Gan S; Ma J; Wu F; Huang Y; Chen Y; Tian W; An C; Sun H; Sun L
    Oncol Rep; 2020 Mar; 43(3):999-1009. PubMed ID: 32020232
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. HIF-1α forms regulatory loop with YAP to coordinate hypoxia-induced adriamycin resistance in acute myeloid leukemia cells.
    Zhu B; Pan S; Liu J; Wang S; Ni Y; Xiao L; Wei Q; Peng Y; Ding Z; Zhao W
    Cell Biol Int; 2020 Feb; 44(2):456-466. PubMed ID: 31617641
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Characterization of Copy Number Variations in Oral Cavity Squamous Cell Carcinoma Reveals a Novel Role for MLLT3 in Cell Invasiveness.
    Wang CI; Kao HK; Chen TW; Huang Y; Cheng HW; Yi JS; Hung SY; Wu CS; Lee YS; Chang KP
    Oncologist; 2019 Dec; 24(12):e1388-e1400. PubMed ID: 31273053
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Inhibition of Siah2 Ubiquitin Ligase by Vitamin K3 Attenuates Chronic Myeloid leukemia Chemo-Resistance in Hypoxic Microenvironment.
    Huang J; Lu Z; Xiao Y; He B; Pan C; Zhou X; Xu N; Liu X
    Med Sci Monit; 2018 Feb; 24():727-735. PubMed ID: 29400343
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance.
    Muz B; Kusdono HD; Azab F; de la Puente P; Federico C; Fiala M; Vij R; Salama NN; Azab AK
    Leuk Lymphoma; 2017 Dec; 58(12):2916-2925. PubMed ID: 28509582
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. IDH mutations associated impact on related cancer epidemiology and subsequent effect toward HIF-1α.
    Semukunzi H; Roy D; Li H; Khan GJ; Lyu X; Yuan S; Lin S
    Biomed Pharmacother; 2017 May; 89():805-811. PubMed ID: 28273642
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (hif1a): An independent predictor of poor overall survival in chronic lymphocytic leukemia.
    Kontos CK; Papageorgiou SG; Diamantopoulos MA; Scorilas A; Bazani E; Vasilatou D; Gkontopoulos K; Glezou E; Stavroulaki G; Dimitriadis G; Pappa V
    Leuk Res; 2017 Feb; 53():65-73. PubMed ID: 28038356
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. HIF-1α inhibition by 2-methoxyestradiol induces cell death via activation of the mitochondrial apoptotic pathway in acute myeloid leukemia.
    Zhe N; Chen S; Zhou Z; Liu P; Lin X; Yu M; Cheng B; Zhang Y; Wang J
    Cancer Biol Ther; 2016 Jun; 17(6):625-34. PubMed ID: 27082496
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Beclin-1 and hypoxia-inducible factor-1α genes expression: Potential biomarkers in acute leukemia patients.
    Radwan SM; Hamdy NM; Hegab HM; El-Mesallamy HO
    Cancer Biomark; 2016 Mar; 16(4):619-26. PubMed ID: 27002764
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications.
    Bashari MH; Fan F; Vallet S; Sattler M; Arn M; Luckner-Minden C; Schulze-Bergkamen H; Zörnig I; Marme F; Schneeweiss A; Cardone MH; Opferman JT; Jäger D; Podar K
    Breast Cancer Res; 2016 Feb; 18(1):26. PubMed ID: 26921175
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML.
    Forristal CE; Brown AL; Helwani FM; Winkler IG; Nowlan B; Barbier V; Powell RJ; Engler GA; Diakiw SM; Zannettino AC; Martin S; Pattabiraman D; D'Andrea RJ; Lewis ID; Levesque JP
    Leukemia; 2015 Oct; 29(10):2075-85. PubMed ID: 25921247
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells.
    Wu L; Yu H; Zhao Y; Zhang C; Wang J; Yue X; Yang Q; Hu W
    Oncotarget; 2015 Feb; 6(6):4406-17. PubMed ID: 25726527
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.